Skip to content

:

Articles related to focusing on healthy aging, prevention, mobility, cognition, nutrition, independence, and caregiving support.

4 min

What is the newest drug for osteoporosis? Understanding the Latest Treatments

In early September 2025, the U.S. Food and Drug Administration (FDA) approved two new biosimilars for denosumab, with Jubbonti® (denosumab-bbdz) being the most recent approval for the treatment of osteoporosis. While the reference product, Prolia, has been on the market for some time, Jubbonti represents the newest entry into the denosumab class of drugs specifically approved to treat osteoporosis.

Read Healthy Aging
5 min

Which osteoporosis medication is best for the spine?

According to the National Institutes of Health, over 53 million people in the United States have osteoporosis or low bone mass. When facing this condition, many wonder: Which osteoporosis medication is best for the spine? This guide explores the options for safeguarding your spinal health.

Read Healthy Aging